GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Inventory Turnover

Enzymotec (Enzymotec) Inventory Turnover : 0.18 (As of Sep. 2017)


View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Enzymotec's Cost of Goods Sold for the three months ended in Sep. 2017 was $4.17 Mil. Enzymotec's Average Total Inventories for the quarter that ended in Sep. 2017 was $23.42 Mil. Enzymotec's Inventory Turnover for the quarter that ended in Sep. 2017 was 0.18.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Enzymotec's Days Inventory for the three months ended in Sep. 2017 was 513.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Enzymotec's Inventory-to-Revenue for the quarter that ended in Sep. 2017 was 1.71.


Enzymotec Inventory Turnover Historical Data

The historical data trend for Enzymotec's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Inventory Turnover Chart

Enzymotec Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Inventory Turnover
Get a 7-Day Free Trial 2.54 3.01 1.09 0.91 0.74

Enzymotec Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.21 0.14 0.26 0.18

Enzymotec Inventory Turnover Calculation

Enzymotec's Inventory Turnover for the fiscal year that ended in Dec. 2016 is calculated as

Inventory Turnover (A: Dec. 2016 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2016 ) / ((Total Inventories (A: Dec. 2015 ) + Total Inventories (A: Dec. 2016 )) / count )
=17.709 / ((21.815 + 26.331) / 2 )
=17.709 / 24.073
=0.74

Enzymotec's Inventory Turnover for the quarter that ended in Sep. 2017 is calculated as

Inventory Turnover (Q: Sep. 2017 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Sep. 2017 ) / ((Total Inventories (Q: Jun. 2017 ) + Total Inventories (Q: Sep. 2017 )) / count )
=4.166 / ((23.094 + 23.751) / 2 )
=4.166 / 23.4225
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enzymotec  (NAS:ENZY) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Enzymotec's Days Inventory for the three months ended in Sep. 2017 is calculated as:

Days Inventory =Average Total Inventories (Q: Sep. 2017 )/Cost of Goods Sold (Q: Sep. 2017 )*Days in Period
=23.4225/4.166*365 / 4
=513.03

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Enzymotec's Inventory to Revenue for the quarter that ended in Sep. 2017 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2017 ) / Revenue (Q: Sep. 2017 )
=23.4225 / 13.672
=1.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Enzymotec Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Enzymotec's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymotec (Enzymotec) Business Description

Traded in Other Exchanges
N/A
Address
Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016